by European Public Health Alliance | Nov 30, 2022 | Antimicrobial Resistance | Analysis & Opinion
By Reneta Ilieva, Bulgarian Association for Patients’ Rights Defence For several months, Bulgarian authorities have been advising practitioners not to prescribe antibiotics for COVID-19, but no significant progress has been achieved in terms of fighting antibiotic...
by European Public Health Alliance | Jul 14, 2022 | Antimicrobial Resistance (AMR), Antimicrobial Resistance | Analysis & Opinion
In its current revision of the EU pharmaceutical legislation, the European Commission (EC) plans to address the increasing burden of antibiotic resistance (AMR) by setting up incentives for the development of new antibiotics. With increasing antimicrobial...
by European Public Health Alliance | May 31, 2022 | Antimicrobial Resistance | Analysis & Opinion
Guest article by Calum MacKichan & Sarah de Maaker – Standing Committee of European Doctors (CPME) The problem of antimicrobial resistance (AMR) is faced by doctors across Europe on a daily basis who are unable to successfully treat patients who have...
by European Public Health Alliance | May 31, 2022 | Antimicrobial Resistance | Analysis & Opinion
Guest article by David Garrahy – World Animal Protection Human health and well-being are intrinsically linked to animal health and welfare. The interconnectedness of both in a healthy environment is the key concept of the One Health policy approach that the European...
by European Public Health Alliance | May 31, 2022 | Antimicrobial Resistance | Analysis & Opinion
The image shows Staphylococcus aureus bacteria. Source: HZI/Manfred Rohde. Guest article by Jens Jäger – Delegate for Health Research at the Helmholtz Office in Brussels. Twitter: @JensJot. Knowledge is power – an old saying with tremendous meaning today. In the...
by European Public Health Alliance | Apr 20, 2022 | Antimicrobial Resistance | Analysis & Opinion, COVID-19, Digital Health | Analysis & Opinion, Healthy Economic Policy | Analysis & Opinion, Non Communicable Diseases (NCDs), Universal Access and Affordable Medicines | Analysis & Opinion
The European Parliament is undertaking an extremely important task of examining how the European Union has dealt with the response to the ongoing COVID-19 pandemic. We know that its impact on almost every aspect of our lives and livelihoods has been and often...
